SARS‐CoV‐2 main protease inhibitory efficacy of natural peptidic α‐hydroxy amides for therapeutic applications of COVID‐19

BACKGROUND: : COVID‐19, a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. Identification and development of drugs/vaccines is urgently needed for prevention and therapy of the COVID‐19 virus (SARS‐CoV‐2) infection. SARS‐CoV‐2 main protease (M(pr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:FASEB J
Main Authors: Yarla, Nagendra, Pathuri, Gopal, Gali, Hariprasad, Terzyan, Simon, Singh, Anil, Scotti, Marcus, Madka, Venkateshwar, Rao, Chinthalapally
Formato: Artigo
Idioma:Inglês
Publicado: The Federation of American Societies for Experimental Biology 2021
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239857/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.03597
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares